WINKAST-L - Montelukast 4mg + Levocetirizine 2.5mg | Intralife Pharmaceuticals
PEDIAHEAL
Top

WINKAST-L

MRP: 88

Packaging: 60ml

Pack Type: suspension

Composition:

Montelukast 4mg + Levocetirizine 2.5mg

Indication:

Seasonal allergic Rhinitis, Perennial Allergic Rhinitis, Chronic idiopathic urticaria, Allergic asthma conditions, Nasal allergy with congestion.

Description:

Montelukast 4 mg + Levocetirizine 2.5 mg is a pediatric-friendly combination that offers dual action against allergic rhinitis, seasonal allergies, asthma symptoms, and chronic urticaria. Levocetirizine, a second-generation antihistamine, blocks histamine release to reduce allergy symptoms like sneezing, itching, and runny nose. Montelukast, a leukotriene receptor antagonist, prevents inflammation in the airways and nasal passages.

Tags:

Pediatric
Allergy Relief
Asthma
Antihistamine
Levocetirizine
Respiratory Care
  • Dual relief from nasal and airway allergic symptoms
  • Reduces sneezing, runny nose, itching, and watery eyes
  • Helps manage mild pediatric asthma and exercise-induced bronchospasm
  • on-sedating; safe for daytime use in children
  • Improves quality of life during allergy seasons

Usage Information

Dosage

Children (2–6 years): 1 tablet or 5 mL syrup once daily (preferably in the evening) Dosage may vary depending on age, weight, and medical history Administer with or without food Always follow pediatrician’s instructions for duration and dosage.

Side Effects

Drowsiness (less common with Levocetirizine) Headache Abdominal pain Dry mouth Rash (rare) Side effects are typically mild and temporary.

Contraindications

Hypersensitivity to Levocetirizine, Montelukast, or any excipient Severe renal impairment Not intended for children under 2 years without medical advice

Availability

Montelukast 4 mg Levocetirizine 2.5 mg, pediatric allergy medicine, kids asthma relief, antihistamine leukotriene blocker, children allergic rhinitis